UPDATE: Credit Suisse Downgrades Stryker Corporation to Neutral on Valuation
Credit Suisse downgraded Stryker Corporation (NYSE: SYK) from Outperform to Neutral.
Credit Suisse said, "We're downgrading SYK to Neutral from Outperform following the stock's recent strong performance, which leaves < 10% upside relative to our unchanged $67 price target. We continue to like SYK's diversified business model, strong FCF generation ability & solid long-term sales growth profile, and do not see SYK shares as particularly expensive (currently trades at 13.3X our 2014 estimate, slightly below the last 5-year average of 13.9X); however, we believe further mid-term valuation / EPS upside is likely to require developments not incorporated in our current forecasts such as above trend-line WW hip/knee market performance, rapid and dramatic improvement in OUS hip/knee execution, &/or added M&A, perhaps in the emerging markets."
Stryker Corporation closed at $63.06 on Wednesday.
Latest Ratings for SYK
|Apr 2016||Sterne Agee CRT||Upgrades||Neutral||Buy|
|Apr 2016||Argus Research||Maintains||Buy|
© 2016 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.